ASHLEY SHEEHAN: Open Payments
NPI 1225734163 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 32 payments from 13 companies in 2025. Trend: 2023 $717 · 2024 $611 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 10 | $154 |
| Averitas Pharma Inc. | 4 | $109 |
| Nalu Medical, Inc. | 3 | $59 |
| Boston Scientific Corporation | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| Medtronic, Inc. | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| Valinor Pharma, LLC | 2 | $26 |
| ConvaTec Inc. | 1 | $26 |
| PFIZER INC. | 1 | $17 |
Products named: Belbuca, QUTENZA, Nalu Neurostimulation System, Intracept, QULIPTA, JOURNAVX, MOVANTIK, AQUACEL AG+.
Industry payments across MD — which companies pay providers there.
